1 / 20

REACH: Impact on Occupational Health

REACH: Impact on Occupational Health. Simon Pickvance University of Sheffield. Previous estimates. RPA TOTAL: 28-54 Billion euros Skin: 11.6-102.9 million euros Respiratory: 4-53 million euros (30 years, discounted, present value). Recognised Occupational diseases in Europe in 2001.

lilia
Download Presentation

REACH: Impact on Occupational Health

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. REACH:Impact on Occupational Health Simon Pickvance University of Sheffield

  2. Previous estimates • RPA • TOTAL: 28-54 Billion euros • Skin: 11.6-102.9 million euros • Respiratory: 4-53 million euros (30 years, discounted, present value)

  3. Recognised Occupational diseases in Europe in 2001 Source: EODS Eurostat, 2004

  4. How many are chemical-related ? (*): including chemical dust Source: extrapolated from EODS Eurostat, 2004

  5. Objective of the ETUC (ongoing) study • Assessment of the impact of REACH on occupational health with a focus on skin and respiratory diseases Why a focus on those 2 occupational diseases ? • Benefits from REACH are underestimated in the RPA study because underdeclaration was not considered • 88 % of occupational skin diseases are related to chemicals exposure • 36 % of occupational respiratory diseases are related to chemicals exposure • Short time lag between exposure and effects (reflecting the present work conditions)

  6. Method of work • Assess number of cases of disease • Estimate the proportion of cases preventable via REACH • Model the impact of REACH • Calculate costs per case • Analyse benefits

  7. How many cases of occupational disease ?The problem with social protection statistics • Systems exclude some sections of the workforce; e.g. self-employed and state employees • Have restrictive definitions of disease • Varying levels of incapacity to qualify (1-33%) • Different routes of access

  8. * In the EU-15 LFS = Labour Force Survey, Eurostat 1999 ad hoc module What other sources of information are available ?

  9. Calculating attributable fractions • Use population prevalence/incidence of the condition • Find out how this varies across occupations • What proportion of cases are expected in each occupational group given its size ? • What proportion could therefore be attributable to work ?

  10. Incidence of three major diseasesEurostat 15/2004, ELFS

  11. Health Benefits from REACH: Assumption: • Information on health effects from chemicals will lead to reduction of exposure and prevention of illness • Some of the chemicals-related occupational diseases are linked to unknown effects from these chemicals

  12. What proportion of exposures could be reduced through REACH ?

  13. Major suspected aetiologies in cases reported by the ONAP in 1997 Kopferschmitt-Kubler et al 2002

  14. Corroboration of estimates • Correction factors: few cases in population studies are compensated • Missed cases (occupation-specific studies) • PARs show good consistency and use different methods of assessing exposure • Other surveys give comparable estimates

  15. % Wheeze at work ECRHS Blanc et al 2003

  16. % Job change attributed to Breathing difficulties Blanc et al 2003

  17. Step 2: Estimation of the economic costs per case per year (RPA) • These costs include: • costs of medical treatment • the value of lost output • human costs (for cancer = value of a statistical life )

  18. Step 3: Economic value of the future diseases avoided as a result of REACH (= results step 1Xresults step 2) (RPA) Skin diseases 0.189 % Respiratory diseases 0.098 % Neuro. diseases 0.126 % Eye disorders 0.001 % € 50 billion over 30 years* Cancer deaths 99,586 % (*): 2000 prices, discounted over 30 years at 3%

  19. Estimated benefits for « real » number of cases: Assumption: real nb of cases = half nb of self-reported cases

  20. Conclusions: • REACH direct costs: € 2.3 billion • REACH benefits for occupational skin and respiratory diseases only : € 1.4 billion REACH is clearly an opportunity to reduce the nb of chemicals-related occupational diseases and the associated costs for both industry and the society

More Related